Renal Cancer - Results from #4920

Systemic antitumor immunity by PD-1/PD-L1 inhibition is potentiated by vascular-targeted photodynamic therapy of primary tumors October 4, 2017

Clinical development of mTor inhibitors for renal cancer October 4, 2017

Asymptomatic Pancreatic Metastasis from Renal Cell Carcinoma Diagnosed 21 Years after Nephrectomy October 4, 2017

Sex-Specific Prognostic Significance of Obesity in Nonmetastatic Clear-Cell Renal-Cell Carcinoma in Korea: A Large Multicenter Cohort Analysis October 3, 2017

Multimodal treatment of advanced renal cancer in 2017 October 3, 2017

Is Cryotherapy a Genuine Rival to Robotic Assisted Partial Nephrectomy in the Management of Suspected Renal Malignancy? a Systematic Review and Meta-Analysis October 2, 2017

Treatment of renal cell carcinoma: Current status and future directions October 2, 2017

The use of intraoperative cell salvage in urologic oncology October 2, 2017

Characterization of Patients With Poor-Risk Metastatic Renal-Cell Carcinoma: Results From a Pooled Clinical Trials Database. October 1, 2017

Expression of inflammatory lipopolysaccharide binding protein (LBP) predicts the progression of conventional renal cell carcinoma - a short report September 29, 2017

Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas September 29, 2017

RPS6KA4/MIR1237 and AURKC promoter regions are differentially methylated in Wilms' tumor September 29, 2017

Surgical resection of locally recurrent renal cell carcinoma after nephrectomy: Oncological outcome and predictors of survival September 29, 2017

Comparison of perioperative, renal and oncologic outcomes in robotic-assisted versus open partial nephrectomy September 29, 2017

Long non-coding RNA HOTAIR promotes cell migration by upregulating insulin growth factor-binding protein 2 in renal cell carcinoma September 28, 2017

Analysis of long non-coding RNA expression profiles in clear cell renal cell carcinoma September 28, 2017

Nivolumab and pembrolizumab: Monoclonal antibodies against programmed cell death-1 (PD-1) that are interchangeable September 28, 2017

Development of Bell's Palsy After Treatment With Ipilimumab and Nivolumab for Metastatic Melanoma: A Case Report September 28, 2017

Venous Thromboembolism Risk in Patients With Locoregional Urothelial Tract Tumors September 28, 2017

A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma September 27, 2017

Page 247 of 456